The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
The currentSurvival package contains functions for the estimation of the current cumulative incidence (CCI) and the current leukaemia-free survival (CLFS). The CCI is the probability that a patient is alive and in any disease remission (e.g. complete cytogenetic remission in chronic myeloid leukaemia) after initiating his or her therapy (e.g. tyrosine kinase therapy for chronic myeloid leukaemia). The CLFS is the probability that a patient is alive and in any disease remission after achieving the first disease remission.
Version: | 1.1 |
Depends: | R (≥ 4.2.0), survival, cmprsk |
Published: | 2022-05-12 |
DOI: | 10.32614/CRAN.package.currentSurvival |
Author: | Eva Koritakova (Janousova), Tomas Pavlik, Jiri Mayer, Ladislav Dusek |
Maintainer: | Eva Koritakova <koritakova at iba.muni.cz> |
License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
NeedsCompilation: | no |
In views: | Survival |
CRAN checks: | currentSurvival results |
Reference manual: | currentSurvival.pdf |
Package source: | currentSurvival_1.1.tar.gz |
Windows binaries: | r-devel: currentSurvival_1.1.zip, r-release: currentSurvival_1.1.zip, r-oldrel: currentSurvival_1.1.zip |
macOS binaries: | r-release (arm64): currentSurvival_1.1.tgz, r-oldrel (arm64): currentSurvival_1.1.tgz, r-release (x86_64): currentSurvival_1.1.tgz, r-oldrel (x86_64): currentSurvival_1.1.tgz |
Old sources: | currentSurvival archive |
Reverse suggests: | RcmdrPlugin.EZR |
Please use the canonical form https://CRAN.R-project.org/package=currentSurvival to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.